Serum triglyceride level in IUGR babies and its comparison with preterm AGA and term normal babies

Area of Science:

• Neonatal Medicine
• Pediatric Cardiology
• Biochemistry

Background:

• Intrauterine growth and birth weight significantly impact infant survival and long-term health.
• Intrauterine growth retardation (IUGR) can alter metabolic programming, particularly lipid metabolism.
• Elevated serum triglyceride levels in IUGR newborns are associated with an increased incidence of coronary heart disease.

Purpose of the Study:

• To compare serum triglyceride (TG) levels in newborns with IUGR, preterm appropriate for gestational age (AGA), and term normal infants.
• To investigate the relationship between IUGR and elevated serum TG as a potential marker for future cardiovascular risk.

Main Methods:

• A cross-sectional study conducted at Bhangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
• Serum TG levels were measured in three groups: IUGR (n=30), preterm AGA (n=30), and term normal (n=30) newborns.
• Blood samples were analyzed using a computerized automated biochemical analyzer; statistical analysis employed the student's 't' test.

Main Results:

• Serum TG levels in IUGR babies (54.4 +/- 11.2 mg/dl) were significantly higher than in term normal babies (38.7 +/- 5.8 mg/dl) (p < 0.05).
• A notable difference in serum TG levels was observed between IUGR and preterm AGA groups, though not explicitly detailed in the abstract.

Conclusions:

• Higher serum triglyceride levels in IUGR newborns indicate a potential predisposition to future coronary heart disease.
• Early identification of elevated TG in IUGR infants may allow for targeted interventions to mitigate long-term cardiovascular risks.